healthdatainsight.org.uk
  • About
    • About
    • Partnerships
    • Contact
  • People
    • The Team
    • Directors
  • Services
    • Data Services
    • Project Management
    • Technology Solutions
    • Consultancy
  • Outputs
    • All projects
    • Publications
  • Work with us
    • Vacancies
    • HDI Internships
  • News
Select Page

First-line treatment patterns and overall survival of patients with advanced Merkel cell carcinoma in England from 2013-2022: results of a nationwide observational cohort study

Oct 20, 2023

Home » Archives for Rosemarie Gant » Page 11 Knott CS, Mahmoudpour SH, Kearney M, Boutmy E, Verpillat P. First-line treatment patterns and overall survival of patients with advanced Merkel cell carcinoma in England from 2013-2022: results of a nationwide observational...

Amivantamab Versus Alternative Real-World Anti-Cancer Therapies in Patients with Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in the US and Europe

Mar 29, 2023

Home » Archives for Rosemarie Gant » Page 11 Girard N, Wolf J, Kim TM, Leighl N, Knott CS, Li T, Cabrieto J, Diels J, Sermon J, Mahadevia P, Schioppa CA, Sabari J. Amivantamab Versus Alternative Real-World Anti-Cancer Therapies in Patients with Advanced Non-Small Cell...

Cohort study to assess geographical variation in cholangiocarcinoma treatment in England

Dec 15, 2023

Home » cholangiocarcinoma Jose S, Zalin-Miller A, Knott C, Paley L, Tataru D, Morement H, Toledano MB, Khan SA. Cohort study to assess geographical variation in cholangiocarcinoma treatment in England. World J Gastrointest Oncol 2023; 15(12): 2077-2092 URL:...

Real-world evidence for patient outcomes and mutational burden in non-small cell lung (NSCLC) cancer patients in England using EGFR biomarker test data from routine clinical care

Nov 12, 2023

Home » Publications » Published 2023 Hagenaars S, Ingleby FC, Lambova A, Gaultney J, Parimi M, Huynh J, Benson S, Muwaffak M, Jose S, Frayling L, Lascano V. https://www.ispor.org/conferences-education/conferences/past-conferences/ispor-europe-2023 Download PDF version...

Real-world outcomes and biomarker testing in cancer patients: exploration of a novel genetic database from routine clinical practice in England

Nov 5, 2023

Home » Publications » Published 2023 Real-world outcomes and biomarker testing in cancer patients: exploration of a novel genetic database from routine clinical practice in England: Fiona C Ingleby, IQVIA, London, UK Saskia P Hagenaars, IQVIA, London, UK Alexandrina...

First-line treatment patterns and overall survival of patients with advanced Merkel cell carcinoma in England from 2013-2022: Results of a nationwide observational cohort study

Oct 21, 2023

Home » Publications » Published 2023 First-line treatment (tx) patterns and overall survival (OS) of patients (pts) with advanced Merkel cell carcinoma (aMCC) in England from 2013-2022: Results of a nationwide observational cohort study C. Knott, S. Mahmoudpour, M....
« Older Entries

Quick Links

About
The Team
Directors
Projects
HDI Internships
News
Contact

Featured Projects

Simulacrum v2
Kidney Cancer UK
PEUGIC
CanGene CanVar
Cholangiocarcinoma

All projects

Contact us |Privacy Policy

Follow Us

Health Data Insight CIC is a Community Interest Company. Registration number 7700799. Registered address: CPC4, Capital Park, Fulbourn, Cambridge CB21 5XE. Copyright © 2025 Health Data Insight CIC

We use cookies as part of our site security. If you continue to use this site we will assume that you are happy with this.